Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain Jan 4, 2017 7:00 am EST
Trevena Reports Third Quarter 2016 Financial Results and Provides Corporate Update Nov 3, 2016 7:00 am EDT
Trevena to Webcast Thought Leader Symposium on Acute Pain Management and Present at the 2016 Annual Meeting of the American Society of Anesthesiologists Oct 17, 2016 4:16 pm EDT
Trevena Reports Second Quarter 2016 Financial Results and Provides Corporate Update Aug 4, 2016 7:00 am EDT
Trevena, Inc. Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of Oliceridine in Acute Pain Jun 8, 2016 7:00 am EDT